Center for Molecular Innovation and Drug Discovery

Design. Create. Innovate.

FUNDING OPPORTUNITIES

Welcome! If you are an investigator interested in applying for funding related to early stage drug discovery or which involves virtual high throughput screening, cheminformatics or synthetic/medicinal chemistry, our experienced team is available to collaborate and provide assistance with building a strong application. For more information about our staff’s expertise and skill sets, explore our ChemCore pages.

Please see below for some current funding opportunities that may interest you.

NIH, PAR-16-041 Drug Discovery for Nervous System Disorders (R01)

This FOA encourages research grant applications directed toward the discovery and preclinical testing of novel compounds for the prevention and treatment of nervous system disorders. For more information, check out the NIH webpage: https://grants.nih.gov/grants/guide/pa-files/PAR-16-041.html

NIH, PAR-16-042 Drug Discovery for Nervous System Disorders (R21)

This FOA encourages research grant applications directed toward the discovery and preclinical testing of novel compounds for the prevention and treatment of nervous system disorders. For more information, check out the NIH webpage: https://grants.nih.gov/grants/guide/pa-files/PAR-16-042.html

NIH, PAR-16-121 Early-Stage Pharmacological Validation of Novel Targets and Accompanying Pre-Therapeutic Leads for Diseases of Interest to the NIDDK (R01)

The goal of this FOA is to translate basic science research into knowledge and tools that can be utilized to provide strong justification for later-phase therapeutics discovery and development efforts in health-related outcomes relevant to the National Institute of Diabetes and Digestive and Kidney Diseases. For more information, check out the NIH webpage: https://grants.nih.gov/grants/guide/pa-files/PAR-16-121.html.

Additional funding opportunities and resources are provided on the Northwestern University Office for Research webpage.